New York, New York (PRWEB) October 16, 2012
Johnson & Johnson, the parent company of DePuy Orthopaedics, continues to bear the costs of its August 2010 DePuy ASR recall, reports Bernstein Liebhard, LLP. According to Johnson & Johnson’s most recent quarterly earnings report, third-quarter profits were off 7.3%, mainly due to costs related to acquisitions and research. In the latest quarter, Johnson & Johnson said it recorded after-tax special items of $553 million that included, among other things, costs related to the DePuy ASR hip replacement recall. The company currently faces thousands of DePuy ASR recall lawsuits stemming from the 2010 recall, most of which are pending in In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products Liability Litigation (“MDL No. 2197”), currently underway in U.S. District Court, Northern District of Ohio.*
“Two years later, the fact that Johnson & Johnson continues to pay a substantial price for the DePuy ASR recall illustrates just how widespread problems with this product really are,” says Bernstein Liebhard LLP, a nationwide law firm that represents victims of defective drugs and medical devices, including DePuy ASR hip implants. The firm continues to investigate potential DePuy ASR hip recall lawsuits on behalf of individuals who experienced premature failure of their hip implant, metallosis, or other injuries allegedly caused by one of these devices.
DePuy ASR Hip Recall Lawsuits
In August 2010, Johnson & Johnson issued a worldwide recall of its DePuy Orthopaedics’ ASR XL Acetabular and ASR Hip Resurfacing hip devices, after data revealed that the metal-on-metal hip replacements were failing early in an unexpectedly high number of people. According to a recent Bloomberg News report, some 6,000 DePuy ASR hip recall lawsuits are pending in the federal litigation in Ohio. Another 2,000 claims are pending in state courts throughout the U.S.** According to court documents, the first DePuy ASR hip recall lawsuit in the federal litigation is scheduled to go to trial on May 6, 2013. The second federal trial is set to begin on July 8, 2013.
DePuy ASR hip recall lawsuits claim the implants shed dangerous amounts of cobalt and chromium ions into surrounding tissue, resulting in a reaction called metallosis, which can lead to tissue death and premature failure of the device. The complaints further allege that the metal ions shed by the metal-on-metal hip implants can accumulate to harmful levels in the bloodstream, putting patients at risk for additional long-term health problems.**
Individuals affected by the DePuy ASR recall may be entitled to compensation for their medical bills, lost wages, pain and suffering, and other damages. Bernstein Liebhard LLP is offering free consultations to victims of the DePuy ASR recall. A wealth of information regarding the problems associated with the DePuy ASR hip replacement device and other metal-on-metal hip implants is available at Bernstein Liebhard LLP’s website, or call 1-877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2012 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. The lawyer responsible for this advertisement in the State of Connecticut is Amy L. Abate. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP